In addition to NT5C2, drug resistance has likely been induced in two type-1 and in two type-2 patients with high expression of MDR1. Overexpression of this gene has previously been reported to cause resistance to drugs used in the treatment of acute leukemia via ATP-dependent drug efflux [36]. This evidence concerns the gene ABCB1 and acute leukemia.